Matt Jonsen

Matt is a partner in Dorsey’s Chem/Bio Practice, where he uses his research experience in genetics, molecular biology, and oncology to help shepherd his client’s technologies from the R&D stage through to issued patents. Matt has helped his clients protect inventions relating to mammalian cells, monoclonal antibodies, plants, microbes, peptides, nucleic acids, chemical therapeutics, molecular diagnostics, and other technologies. His clients include established and emerging companies and research universities focused on diverse fields, including biopharmaceuticals, stem cell preservation and therapies, medical devices, DNA sequencing, human genetics, cannabis, animal husbandry, and renewable energy.

With his deep biotech background, Matt helps develop and manage patent portfolios, and he provides strategic counseling relating to patent and trade secret protection, diligence, transfer, acquisition, and licensing. Matt has experience protecting clients’ portfolios in the United States and more than 50 countries world-wide. Matt understands the issues faced by both emerging and established companies.

Matt received his Ph.D. from the University of Utah School of Medicine, and a B.A. in Molecular Cellular and Developmental Biology from the University of Colorado at Boulder. His doctoral work focused on gene transcription and regulation of DNA-protein interaction. Matt has extensive post-doctoral experience in human genetics and mammalian transcription factor regulation, most recently in the Department of Endocrinology at the University of Colorado School of Medicine. He received his J.D. from The University of Denver College of Law.